Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseLeukemiaBone MarrowWhole-Body IrradiationBone Marrow CellsTissue DonorsAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteCytomegalovirus InfectionsTransplantation ConditioningTransplantation ChimeraHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft SurvivalLymphocyte DepletionImmunosuppressive AgentsRecurrenceBone and BonesNuclear FamilyLymphocyte TransfusionAcute DiseaseHematopoietic Stem Cell TransplantationCyclosporineHistocompatibility TestingTransplantation, AutologousTime FactorsRemission InductionCytomegalovirusT-LymphocytesHistocompatibilityBusulfanTreatment OutcomeRadiation ChimeraCombined Modality TherapyHematopoietic Stem CellsGraft vs Host ReactionLeukocyte TransfusionSurvival AnalysisImmunosuppressionRetrospective StudiesGraft vs Tumor EffectMice, Inbred C57BLGraft RejectionTransplantation, IsogeneicCyclophosphamideImmunocompromised HostHematopoiesisBone Marrow PurgingGraft vs Leukemia EffectFatal OutcomeLeukemia, MyeloidChimeraLeukemia, LymphoidMyelodysplastic SyndromesHepatic Veno-Occlusive DiseaseOpportunistic InfectionsHLA AntigensHematologic DiseasesBone Marrow DiseasesBone RemodelingBone Marrow ExaminationMice, Inbred BALB CLiving DonorsLeukemia, Lymphocytic, Chronic, B-CellGanciclovirBlood DonorsPneumonia, ViralMycosesBone Marrow NeoplasmsLeukemia, ExperimentalSpleenSurvival RateActuarial AnalysisFlow CytometryTransplantation ImmunologyColony-Forming Units AssayLymphoma, Non-HodgkinAspergillosisPolymerase Chain ReactionKidney TransplantationLeukocyte CountFollow-Up StudiesAntilymphocyte SerumDisease-Free SurvivalLeukemia, Myelomonocytic, AcuteMethotrexateCell DifferentiationBone DensityInfectionBlood Group IncompatibilityMucormycosisAntineoplastic Combined Chemotherapy ProtocolsCells, CulturedSevere Combined ImmunodeficiencyImmunophenotypingGranulocyte Colony-Stimulating FactorLymphocyte Culture Test, Mixed